SBC Medical Group Holdings (Location: California, USA; CEO: Yoshiyuki Aikawa; hereinafter 'SBC'), which provides management support to medical institutions both domestically and internationally, is pleased to announce the opening of 'NEO Skin Clinic Ginza' today, Saturday, March 28, 2026. Starting today, the clinic will offer 'QUADESSY,' a next-generation, two-stage heating skin treatment that combines 'pre-heating'—which warms the skin before irradiation—with microneedle RF technology. SBC is accelerating its multi-branding strategy to meet diversifying needs. Its flagship brand, 'NEO Skin Clinic,' operates under the concept of 'making popular Korean-style skin management more accessible.' The new flagship store has opened in Ginza, a competitive beauty hub and a center for medical tourism. ● About 'QUADESSY' 'QUADESSY' is a two-stage heating skin treatment that combines 'pre-heating' with microneedle RF. Designed to create precise coagulation in the dermis while the skin is stabilized, it achieves stable energy delivery and gradual energy transmission through proprietary control functions, while also being designed to reduce the burden during the procedure. It addresses skin concerns such as pores, fine lines, acne scars, and sagging. This treatment is available at 'NEO Skin Clinic Ginza' starting today, with promotional pricing available until Saturday, June 27, 2026. ・ Key Features of 'QUADESSY' 1. Unique 'Pre-heating' Function: By warming the skin surface immediately before needle insertion, it adjusts skin resistance and is designed to reduce the burden during insertion. By delivering RF energy while the skin is stabilized, it aims to form uniform coagulation in the dermis. 2. Multi-layer Approach via 'Double Depth': Proprietary control technology allows for the delivery of high-frequency energy to both 'shallow' and 'deep' layers in a single shot, enabling a gradual heating approach from the surface to the depths. 3. 'Drug Delivery' Function: This feature aims to deliver beauty ingredients into the skin layers through micro-channels created by the microneedles. It is possible to select agents such as PDLLA or PDRN formulations tailored to each individual's skin condition. ・ Risks and Side Effects This treatment is elective and not covered by public health insurance. Redness, swelling, bruising, and a sensation of heat may occur after the procedure. In rare cases, mild pain may occur, and symptoms and their severity vary by individual. Details will be explained by a doctor during the consultation. For more information about 'QUADESSY' and campaign details, please visit here. ● Comment from Dr. Soichiro Morikawa, Director of NEO Skin Clinic Ginza

FACT BOX

  • Source: PR Times
  • Category: News